Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

LONDON, July 9, 2026 /PRNewswire/ — Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX) announced today that it has entered into a definitive agreement for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of… Source: prnewswire Country: United States

ACHP Forms Patient Advisory Council to Elevate Patient Voices in Chronic Disease Research

WASHINGTON, July 9, 2026 /PRNewswire/ — The Alliance of Community Health Plans (ACHP) is amplifying patients’ voices on chronic disease research via its newly launched Patient Advisory Council. The council’s purpose is to ensure patient perspectives remain at the center of ACHP’s… Source: prnewswire Country: United States